EDGAR Filing Documents for 0001479290-20-000042

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001479290-20-000042

Filing Date

2020-02-26

Accepted

2020-02-26 16:29:25

Documents

Period of Report

2019-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	rvnc1231201910-k.htm iXBRL	10-K	2712141
2	EXHIBIT 4.4	fy1910-kex44descriptio.htm	EX-4.4	26531
3	EXHIBIT 10.27	fy1910-kex1027director.htm	EX-10.27	20460
4	EXHIBIT 10.28	fy1910-kex1028mgtbonus.htm	EX-10.28	4803
5	EXHIBIT 10.40	fy1910-kex1040employme.htm	EX-10.40	44371
6	EXHIBIT 10.41	fy1910-kex1041executiv.htm	EX-10.41	81112
7	EXHIBIT 10.42	fy1910-kex1042revancex.htm	EX-10.42	56864
8		fy1910-kexhibit1043teo.htm	EX-10.43	802543
9	EXHIBIT 21.1	fy1910-kex211listofsub.htm	EX-21.1	1557
10	EXHIBIT 31.1	fy1910-kex311certifica.htm	EX-31.1	9113
11	EXHIBIT 31.2	fy1910-kex312certifica.htm	EX-31.2	9290
12	EXHIBIT 32.1	fy1910-kex321certifica.htm	EX-32.1	7701
13	EXHIBIT 32.2	fy1910-kex322certifica.htm	EX-32.2	7717
19		revancepipelinechart2020a01.jpg	GRAPHIC	160940
20		rvncstockperformancegraph201.jpg	GRAPHIC	78863
	Complete submission text file	0001479290-20-000042.txt		12000018

Data Files

Seq	Description	Document	Type	Size
14	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	rvnc-20191231.xsd	EX-101.SCH	53657
15	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	rvnc-20191231_cal.xml	EX-101.CAL	93250
16	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	rvnc-20191231_def.xml	EX-101.DEF	311731
17	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	rvnc-20191231_lab.xml	EX-101.LAB	835993
18	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	rvnc-20191231_pre.xml	EX-101.PRE	508440
84	EXTRACTED XBRL INSTANCE DOCUMENT	rvnc1231201910-k_htm.xml	XML	1753820

Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560

Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400

Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)